Balyasny Asset Management L.P.
Position in MLTX — MoonLake Immunotherapeutics
CIK 1218710
Chicago, IL
Position in MLTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,770,561
-$2,092,409 QoQ
Shares Held
912,715
-14.3% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 172 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Derivatives in MLTX
reported options exposure · as of Sep 30, 2025CallValue
$212,949
CallShares
29,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. MLTX ranks #41 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in MLTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,770,561 | 912,715 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,862,970 | 1,065,610 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,706,715 | 1,571,071 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $212,949 | 29,700 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $12,183,514 | 1,699,235 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,973,624 | 423,170 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,080,083 | 78,835 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,185,657 | 206,568 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,161,284 | 360,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,690,044 | 584,263 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,332,429 | 424,695 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $36,144,018 | 598,510 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $13,352,250 | 234,250 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,536,391 | 69,341 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,228,952 | 197,707 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,288,989 | 217,999 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $775,022 | 99,874 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||